The F-circEA-2a exists in the tumor, but not in the plasma of NSCLC patients with EML4-ALK fusion gene, further indicating that F-circEA has a significant diagnostic value for the diagnosis of EML4-ALK-positive NSCLC. The gene discussed is ALK; the disease is neoplasm.